Yousuke Furuta Selected Research

Yousuke Furuta Research Topics

Disease

36	Infections 01/2023 - 08/2002
19	Human Influenza (Influenza) 01/2018 - 09/2003
9	Virus Diseases (Viral Diseases) 01/2018 - 09/2007
5	Body Weight (Weight, Body) 01/2018 - 06/2007
4	Fever (Fevers) 01/2017 - 01/2008
3	Severe Fever with Thrombocytopenia Syndrome 01/2021 - 02/2017
3	Lassa Fever (Fever, Lassa) 01/2018 - 10/2015
3	American Hemorrhagic Fever (Bolivian Hemorrhagic Fever) 09/2017 - 01/2013
3	Weight Loss (Weight Reduction) 09/2015 - 06/2007
2	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 04/2016
2	Viremia 01/2020 - 10/2013
2	Rabies (Hydrophobia) 12/2019 - 04/2016
2	Herpesviridae Infections (Herpesvirus Infection) 06/2014 - 06/2010
2	Thrombocytopenia (Thrombopenia) 01/2013 - 10/2011
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2023
1	Foot-and-Mouth Disease 12/2022
1	Henipavirus Infections 01/2018
1	Disease Progression 01/2018
1	Bunyaviridae Infections 02/2016
1	Arenaviridae Infections 09/2015
1	Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever) 09/2015
1	Phlebotomus Fever (Sandfly Fever) 11/2013
1	Poliomyelitis (Polio) 11/2013
1	Rift Valley Fever 11/2013
1	Yellow Fever 11/2013
1	Hantavirus Pulmonary Syndrome 10/2013
1	RNA Virus Infections 10/2011
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 05/2011
1	Western Equine Encephalomyelitis (Encephalitis, Western Equine) 06/2009
1	West Nile Fever 12/2008
1	Weight Gain 06/2007
1	Calculi (Calculus) 08/2002

Drug/Important Bio-Agent (IBA)

34	favipiravirIBA 01/2023 - 06/2009
25	Antiviral Agents (Antivirals)IBA 01/2023 - 09/2003
9	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 01/2008
8	Oseltamivir (Tamiflu)FDA Link 06/2014 - 09/2003
7	Viral RNAIBA 01/2021 - 06/2009
5	VaccinesIBA 01/2022 - 04/2014
5	Neuraminidase (Sialidase)IBA 06/2014 - 01/2010
4	PyrazinesIBA 02/2011 - 01/2008
3	Interferon Type IIBA 01/2020 - 11/2017
3	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2016 - 06/2009
3	T 1106IBA 05/2010 - 06/2007
2	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2022 - 01/2018
2	Therapeutic UsesIBA 01/2018 - 08/2002
2	Immunoglobulins (Immunoglobulin)IBA 04/2016 - 02/2016
2	peramivirIBA 06/2014 - 04/2012
2	Zanamivir (Relenza)FDA Link 06/2014 - 08/2010
1	T 1105IBA 12/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	2'-fluoro-2'-deoxycytidineIBA 01/2021
1	Fibrinolysin FDA Link 09/2019
1	FibrinIBA 09/2019
1	purineIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 02/2017
1	Drug CombinationsIBA 06/2014
1	Investigational DrugsIBA 06/2014
1	AntigensIBA 10/2013
1	Ion Channels (Ion Channel)IBA 01/2013
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 01/2013
1	RibonucleoproteinsIBA 01/2013
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2011
1	IntegrinsIBA 05/2011
1	Histidine (L-Histidine)FDA Link 08/2010
1	Tyrosine (L-Tyrosine)FDA Link 08/2010
1	Pyrazinamide FDA LinkGeneric 01/2010
1	Neutralizing AntibodiesIBA 08/2009
1	EnzymesIBA 06/2009
1	salicylhydroxamic acid (SHAM)IBA 06/2007
1	Alanine Transaminase (SGPT)IBA 06/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2002
1	Mesylates (Mesylate)IBA 08/2002

Therapy/Procedure

9	Therapeutics 01/2023 - 01/2008
3	Oral Administration 01/2018 - 09/2003
1	Organ Transplantation 01/2018
1	Intravenous Administration 08/2002